Presentation on theme: "Features of Canine Conjunctival Melanocytic Tumors Reilly CM, Dubielzig RR, Newman SJ and Bergman PJ."— Presentation transcript:
Features of Canine Conjunctival Melanocytic Tumors Reilly CM, Dubielzig RR, Newman SJ and Bergman PJ
Purposes A retrospective study of the histologic and biologic features of canine conjunctival melanocytic tumors Compare to results of prior studies Biologic behavior and histologic characteristics of canine conjunctival melanomas. Collins BK, Collier LL, Miller MA, Linton LL. Prog in vet and comparative ophthalmology; 3:135-140, 1993.
Methods Cases of conjunctival melanocytic tumors selected (COPLOW and AMC) Follow-up surveys mailed to submitting ophthalmologists Only cases with follow-up available were included
Methods (cont.) Slides were evaluated for: Pigmentation Intra- and subepithelial packeting Criteria of malignancy Cell type(s) Mitotic index Necrosis Epithelial dysplasia
Methods (cont.) Survey information included: Breed, gender, age at diagnosis Tumor location (bulbar, TEL, palpebral) Surgery type (incisional, excisional, enucleation, exenteration) Recurrence, metastasis and death
Results 63 cases were identified 24 had follow-up available 14 males, 10 females 8 mixed breeds, 3 labs, 2 cockers, 2 Weimaraners, 2 Shar-peis 1 each Schnauzer, German Shepherd, Poodle, Golden Retriever, Boston Terrier, Pekingese, Newfoundland Age at diagnosis 6-14 y (11.5)
Results – Location 14/23 (61%) on TEL 5/23 (22%) on bulbar conjunctiva 4/23 (17%) on palpebral conjunctiva Location not provided for one tumor
Results - Histologic patterns 14/24 (60%) had packeting of neoplastic cells within conj. epithelium 19/24 (83%) had packeting in subepithelial stroma No correlation with recurrence or metastasis Can be helpful in diagnosis of amelanotic tumors
Results – Tumor related death Only 2 tumors (10%) metastasized Both from palpebral conjunctiva 1 dog (5%) euthanized for aggressive regrowth Also from palpebral conjunctiva No dogs with TEL or bulbar tumors died from tumor Palpebral tumors more advanced at diagnosis?
Conclusions Similar to prior report EXCEPT: Even male: female ratio Shar-peis also over represented Metastatic risk may be lower (10% v. 17%) Recurrence even with aggressive surgery Stresses the need for assertive follow-up Especially rare diseases
Acknowledgements Co-authors: Dr. Dick Dubielzig, Rebecca Morris, Dr. Shelley Newman, Dr. Phillip Bergman Technical Assistance: Kate Leiber